Skip to content
10-Q

Quarterly Report

Aeon Global Health Corp.

0001437749-19-002620

← back to feed
Filed
Feb 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Jan 21, 2019 7.42M sh
Shares Diluted Q2 2019 · Dec 31, 2018 7.38M sh
Shares Diluted Q2 2019 · Dec 31, 2018 7.38M sh
Shares Diluted Q2 2019 · Dec 31, 2017 7.25M sh
Shares Diluted Q2 2019 · Dec 31, 2017 7.25M sh
Operating Cash Flow Q2 2019 · Dec 31, 2018 −$400.66K
Operating Cash Flow restated Q2 2019 · Dec 31, 2017 −$885.29K
Cash And Equivalents Q2 2019 · Dec 31, 2018 $322.69K
Cash And Equivalents Q2 2019 · Jun 30, 2018 $723.35K
Stockholders Equity Q2 2019 · Dec 31, 2018 $1.56M
Stockholders Equity Q2 2019 · Jun 30, 2018 $488.55K
Current Liabilities Q2 2019 · Dec 31, 2018 $5.21M
Current Liabilities Q2 2019 · Jun 30, 2018 $10.35M
Total Liabilities Q2 2019 · Dec 31, 2018 $8.78M
Total Liabilities Q2 2019 · Jun 30, 2018 $10.49M
Current Assets Q2 2019 · Dec 31, 2018 $3.35M
Current Assets Q2 2019 · Jun 30, 2018 $3.74M
Total Assets Q2 2019 · Dec 31, 2018 $10.34M
Total Assets Q2 2019 · Jun 30, 2018 $10.98M
Eps Diluted Q2 2019 · Dec 31, 2018 −$0.04
Eps Diluted Q2 2019 · Dec 31, 2018 −$0.10
Eps Diluted Q2 2019 · Dec 31, 2017 −$0.42
Eps Diluted Q2 2019 · Dec 31, 2017 −$0.59
Eps Basic Q2 2019 · Dec 31, 2018 −$0.04
Eps Basic Q2 2019 · Dec 31, 2018 −$0.10
Eps Basic Q2 2019 · Dec 31, 2017 −$0.42
Eps Basic Q2 2019 · Dec 31, 2017 −$0.59
Sga Expense Q2 2019 · Dec 31, 2018 $2.52M
Sga Expense Q2 2019 · Dec 31, 2018 $4.7M
Sga Expense restated Q2 2019 · Dec 31, 2017 $3.04M
Sga Expense Q2 2019 · Dec 31, 2017 $6.15M
Net Income Q2 2019 · Dec 31, 2018 −$175K
Net Income Q2 2019 · Dec 31, 2018 −$584.22K
Net Income Q2 2019 · Dec 31, 2017 −$2.98M
Net Income Q2 2019 · Dec 31, 2017 −$4.11M
Operating Income Q2 2019 · Dec 31, 2018 −$612.61K
Operating Income Q2 2019 · Dec 31, 2018 −$700.23K
Operating Income Q2 2019 · Dec 31, 2017 $1.38M
Operating Income Q2 2019 · Dec 31, 2017 $243.64K
Cost Of Revenue Q2 2019 · Dec 31, 2018 $1.2M
Cost Of Revenue Q2 2019 · Dec 31, 2018 $2.66M
Cost Of Revenue restated Q2 2019 · Dec 31, 2017 $888.54K
Cost Of Revenue restated Q2 2019 · Dec 31, 2017 $2.02M